GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rubicon Organics Inc (TSXV:ROMJ) » Definitions » EBIT

Rubicon Organics (TSXV:ROMJ) EBIT : C$-1.66 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Rubicon Organics EBIT?

Rubicon Organics's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was C$0.12 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was C$-1.66 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Rubicon Organics's annualized ROC % for the quarter that ended in Sep. 2024 was 1.65%. Rubicon Organics's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 1.31%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Rubicon Organics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -5.71%.


Rubicon Organics EBIT Historical Data

The historical data trend for Rubicon Organics's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubicon Organics EBIT Chart

Rubicon Organics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial -9.67 -12.09 -13.27 -2.83 -

Rubicon Organics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.37 - -1.61 -0.17 0.12

Competitive Comparison of Rubicon Organics's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Rubicon Organics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rubicon Organics's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rubicon Organics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Rubicon Organics's EV-to-EBIT falls into.


;
;

Rubicon Organics EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.66 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rubicon Organics  (TSXV:ROMJ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Rubicon Organics's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=0.632 * ( 1 - 0% )/( (37.952 + 38.494)/ 2 )
=0.632/38.223
=1.65 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Rubicon Organics's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0.468/( ( (24.439 + max(10.994, 0)) + (23.927 + max(12.059, 0)) )/ 2 )
=0.468/( ( 35.433 + 35.986 )/ 2 )
=0.468/35.7095
=1.31 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(5.046 + 11.963 + 2.414) - (8.43 + 0 + -0.0010000000000012)
=10.994

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.146 + 11.146 + 2.496) - (7.562 + 0 + 0.167)
=12.059

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Rubicon Organics's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=-1.661/29.090
=-5.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rubicon Organics EBIT Related Terms

Thank you for viewing the detailed overview of Rubicon Organics's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Rubicon Organics Business Description

Traded in Other Exchanges
Address
744 West Hastings Street, Unit 505, Vancouver, BC, CAN, V6C 1A5
Rubicon Organics Inc is engaged in the business of the production and sale of cannabis in Canada. The Company produces and processes organic cannabis at its wholly-owned, federally licensed facility in Delta, British Columbia which it sells under its wholly owned and other licensed brands such as Lab Theory, Wildflower, Homestead Cannabis Supply, 1964 Supply Co, and Simply Bare Organic.
Executives
Lenard Boggio Director
John Pigott Director
Karen Proud Director
Eric Savics 10% Security Holder
Michael Erik Detlefsen Director
Margaret Brodie Director, Senior Officer
Jesse Mcconnell 10% Security Holder, Director, Senior Officer
Pierre Lassonde 10% Security Holder
Peter Doig Senior Officer
John Bryan Disher Director

Rubicon Organics Headlines

No Headlines